Tackling bad cholesterol levels with statins may reduce dementia risk
Cholesterol-busting drugs have been linked to reducing the risk of dementia in a new study.
Statins are one of the most commonly prescribed drugs in the UK, with around seven to eight million people taking them to cut their chance of heart attack and stroke.
Now new research suggests they may have more benefits.
Experts found that people who have low levels of 'bad' cholesterol in their blood have a reduced risk of dementia, including Alzheimer's disease.
And use of statins was found to have 'additional protective effects'.
Statins are a group of medicines that can help lower the level of low-density lipoprotein (LDL) cholesterol in the blood.
LDL cholesterol (LDL- C) is often referred to as 'bad cholesterol' and can cause plaque to build in arteries, leading to cardiovascular disease, which can increase the chance of strokes, heart attacks and death.
Researchers from South Korea said their findings 'underscore the crucial role of managing LDL- C in lowering dementia risk'.
Experts examined health data on more than 570,000 people in South Korea.
The NHS says that people should aim for bad cholesterol levels in the blood to be below 4mmol/L (millimoles per litre).
Researchers found that people whose LDL cholesterol levels were below 1.8 mmol/L had a 26% reduced risk of dementia and a 28% reduced risk in Alzheimer's compared to those who have LDL cholesterol levels above 3.4 mmol/L.
Statin use appeared to have additional protection against dementia in the presence of low LDL cholesterol levels.
Among people with LDL cholesterol levels below 1.8 mmol/L, statin use was linked to a 13% reduction in dementia risk and a 12% decrease in risk of Alzheimer's disease compared with non-users.
'These findings emphasise the importance of targeted LDL- C management as part of dementia prevention strategies, with potential integration into clinical guidelines,' the authors wrote in the Journal of Neurology Neurosurgery and Psychiatry.
'The results support the use of statin therapy within specific LDL- C ranges for both cardiovascular and cognitive health benefits.'
They added: 'This insightful understanding of how statin use interacts with LDL- C levels emphasises the need for personalised statin prescriptions, focusing on achieving LDL- C levels that offer the maximum cognitive benefits.'
Commenting on the study, Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'This large study looked at patient records for levels of LDL cholesterol and the risk of dementia, it also examined those patients who were on statins.
'It found that those people with lower LDL levels had a reduced risk of dementia.
'The use of statins seemed to offer a protective effect – even in those who already had cholesterol levels within a lower range.
'However, dementia risk is complex and influenced by many factors. Without a detailed picture of what's going on in the brain we do not know if there is a direct link between lower cholesterol and reduced dementia risk. Clinical trials will be key to understand what effects statins might be having on disease processes in the brain.
'In the meantime, keeping our hearts healthy remains one of the most effective ways we can protect our brain health. If you have any concerns about your cholesterol levels, you should speak to your GP.'
Dr Richard Oakley from the Alzheimer's Society added: ' Dementia risk is complicated and determined by several factors including genetics, lifestyle, and the environment.
'This study adds to our understanding by showing the strong connection between heart and brain health. Simply put, what is good for the heart is good for the head.'
He added: 'This is an ever-evolving topic, and more targeted research and trials are needed to understand whether statins can help protect the brain. However, it is crucial to talk to your GP before making any changes to your medication'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
32 minutes ago
- BBC News
Canterbury GP's genital exams 'unnecessary', court hears
A former GP conducted "unnecessary" genital examinations on nine male patients, including young teenagers, a court has Manson, 56, is alleged to have carried out the exams for complaints including coughs, headaches and knee accusers said they did not recall him wearing gloves, offering a chaperone or giving "proper explanations" for the examinations before they took at Canterbury Crown Court on Monday, Dr Manson, of Tower Way, Canterbury, denied 18 offences of sexual assault and six of indecent assault. The court heard that Dr Manson worked as a GP between 1994 and 2017, along with working as a GP trainer and programme director of GP training, and as a GP appraiser for the General Medical first complaint of sexual assault against him was filed to Canterbury Police in 2017, followed by an NHS England exercise which saw more alleged victims come a police interview, he said he had never touched a patient for improper or sexual purposes and said every examination was conducted for justified medical reasons, the court was Jennifer Knight KC told jurors Manson also failed to document in patients' notes any potential findings or the the fact such examinations had taken place at all. The first two alleged victims were brothers and both saw Manson before and after they were 16, the court said they were told to pull down their trousers and boxer shorts during a number of Knight said that the elder brother initially "assumed" this was necessary but had gradually become "uncomfortable".Their mother told investigators she never met Dr Manson when her sons were young teenagers as she would always stay in the waiting room, the court heard. Another alleged victim saw Dr Manson twice in 1999 when he was 35 and then 12 years later in 2011, each time with abdominal all three occasions, a genital examination was undertaken and, on both occasions in 1999, his underwear was removed without consent, the court Manson told police this had been necessary to check lymph nodes and femoral pulses in the victim's groin area. However, Ian Wall, a forensic medicine professor and GP, noted there would be no reason to do this, especially without trial continues.
Daily Mail
an hour ago
- Daily Mail
Using an asthma inhaler in the wrong way could cause your TEETH to fall out - but this simple trick can protect you: DR MARTIN SCURR
My 38-year-old daughter was recently told by her dentist she was suffering from a lack of bone density which could lead to tooth loss due to her use of inhalers prescribed for her life-long asthma. We're devastated, particularly as this was never pointed out by doctors or the asthma clinic. If she needs dental bone grafts, would the NHS pay? Norma Divine, Solihull.
BBC News
an hour ago
- BBC News
Baby girl given overdose before death, Manchester inquest hears
A "very sick" newborn baby girl died shortly after accidently being given a large overdose of medication, an inquest has Lindop died within 24 hours of being born at Manchester's St Mary's Hospital on 13 March Coroners Court was told nurses in the neo-natal intensive care unit mistakenly gave the baby 10 times the dose of a drug she was a medical expert in the case said Polly's condition was already deteriorating and there was a "very low" chance of her surviving, even without the overdose. Polly, who was born 10 weeks prematurely, suffered a cardiac arrest 10 minutes after being given the excessive dose of the drug court heard medics made a mistake entering the dosage on the infusion mother Kimberley Lindop told the court her daughter had gone from being "fine to very poorly in 45 minutes". She described a "chaotic" scene as hospital staff tried to save the child, who died a few hours later after suffering a second cardiac court heard the nurses involved and Manchester University NHS Foundation Trust had accepted the overdose mistake had been made. 'Difficult to speculate' Mrs Lindop said the family had not been told the details of the mistake at the time but "just knew something had happened".However, a post-mortem examination found the primary cause of Polly's death was sepsis and prematurity and that she had suffered severe lung Naomi Carter, a former Home Office forensic pathologist who jointly carried out the post-mortem examination, said it was "difficult to speculate" on how much difference the medication overdose had made in Polly's death."It may have hastened the event of the cardiac arrest", she told the Dr Carter said Polly was "a very, very sick infant" in a critical condition who would "more likely than not died of her medical problems", even without the Manchester Police launched an investigation into possible gross negligence manslaughter at the time but earlier this year said no criminal charges were being Ch Insp Mark Davis told the court that after liaising with the Crown Prosecution Service, it was decided there was "no realistic chance of prosecution."The inquest continues. Listen to the best of BBC Radio Manchester on Sounds and follow BBC Manchester on Facebook, X, and Instagram. You can also send story ideas via Whatsapp to 0808 100 2230.
